Exposure limits · European Union
European Union exposure limits: Indicative occupational exposure limit values (IOELV) under 98/24/EC
Member states must set national limits taking these into account; the national value applies at the workplace. 158 limit values, version 2021-05-20. Check the substances in section 3 and the limits in section 8 of your safety data sheets against this list.
- Legal status
- indicative (IOELV) and binding (BOELV)
- Version date
- 2021-05-20
- Values
- 158
- Guide
- European Union rules
Limit values
158 rows
| Substance | CAS | EC | 8 h ppm | 8 h mg/m³ | 15 min ppm | 15 min mg/m³ | Fraction | Notes |
|---|---|---|---|---|---|---|---|---|
| Picric acid | 88-89-1 | 2 018 659 | 0,1 | (6) | ||||
| Naphtalene | 91-20-3 | 2 020 495 | 10 | 50 | ||||
| Pyridine | 110-86-1 | 2 038 099 | 5 | 15 | (6) | |||
| Cresols (all isomers) | 1319-77-3 | 2 152 932 | 5 | 22 | (6) | |||
| Platinum (metallic) | 7440-06-4 | 2 311 161 | 1 | (6) | ||||
| Tin (inorganic compounds as Sn) | 2 | (6) | ||||||
| Diethylether | 60-29-7 | 200-467-2 | 100 | 308 | 200 | 616 | ||
| Acetone | 67-64-1 | 200-662-2 | 500 | 1 210 | ||||
| Chloroform | 67-66-3 | 200-663-8 | 2 | 10 | Skin | |||
| 1,1,1-Trichloroethane | 71-55-6 | 200-756-3 | 100 | 555 | 200 | 1 110 | ||
| Ethylamine | 75-04-7 | 200-834-7 | 5 | 9,4 | ||||
| 1,1-Dichloroethane | 75-34-3 | 200-863-5 | 100 | 412 | Skin | |||
| Phosgene | 75-44-5 | 200-870-3 | 0,02 | 0,08 | 0,1 | 0,4 | ||
| Chlorodifluoromethane | 75-45-6 | 200-871-9 | 1 000 | 3 600 | ||||
| Butanone | 78-93-3 | 201-159-0 | 200 | 600 | 300 | 900 | ||
| Propionic acid | 79-09-4 | 201-176-3 | 10 | 31 | 20 | 62 | ||
| o-Xylene | 95-47-6 | 202-422-2 | 50 | 221 | 100 | 442 | Skin | |
| 1,2-Dichlorobenzene | 95-50-1 | 202-425-9 | 20 | 122 | 50 | 306 | Skin | |
| 1,2,4-Trimethylbenzene | 95-63-6 | 202-436-9 | 20 | 100 | ||||
| 2-Phenylpropene | 98-83-9 | 202-705-0 | 50 | 246 | 100 | 492 | ||
| Ethylbenzene | 100-41-4 | 202-849-4 | 100 | 442 | 200 | 884 | Skin | |
| e-Caprolactam, (dust and vapour) | 105-60-2 | 203-313-2 | 10 | 40 | ||||
| Heptan-3-one | 106-35-4 | 203-388-1 | 20 | 95 | ||||
| p-Xylene | 106-42-3 | 203-396-5 | 50 | 221 | 100 | 442 | Skin | |
| Allyl alcohol | 107-18-6 | 203-470-7 | 2 | 4,8 | 5 | 12,1 | Skin | |
| Ethylene glycol | 107-21-1 | 203-473-3 | 20 | 52 | 40 | 104 | Skin | |
| 1-Methoxypropanol-2 | 107-98-2 | 203-539-1 | 100 | 375 | 150 | 568 | Skin | |
| 4-Methylpentan-2-one | 108-10-1 | 203-550-1 | 20 | 83 | 50 | 208 | ||
| m-Xylene | 108-38-3 | 203-576-3 | 50 | 221 | 100 | 442 | Skin | |
| 2-Methoxy-1-methylethylacetate | 108-65-6 | 203-603-9 | 50 | 275 | 100 | 550 | Skin | |
| Mesitylene (Trimethylbenzenes) | 108-67-8 | 203-604-4 | 20 | 100 | ||||
| Cyclohexanone | 108-94-1 | 203-631-1 | 10 | 40,8 | 20 | 81,6 | Skin | |
| Tetrahydrofuran | 109-99-9 | 203-726-8 | 50 | 150 | 100 | 300 | Skin | |
| 5-Methylhexan-2-one | 110-12-3 | 203-737-8 | 20 | 95 | ||||
| Heptan-2-one | 110-43-0 | 203-767-1 | 50 | 238 | 100 | 475 | Skin | |
| Piperazine | 110-85-0 | 203-808-3 | 0,1 | 0,3 | ||||
| 2-Butoxyethanol | 111-76-2 | 203-905-0 | 20 | 98 | 50 | 246 | Skin | |
| 2-Butoxyethyl acetate | 112-07-2 | 203-933-3 | 20 | 133 | 50 | 333 | Skin | |
| Dimethylether | 115-10-6 | 204-065-8 | 1 000 | 1 920 | ||||
| 1,2,4-Trichlorobenzene | 120-82-1 | 204-428-0 | 2 | 15,1 | 5 | 37,8 | Skin | |
| Triethylamine | 121-44-8 | 204-469-4 | 2 | 8,4 | 3 | 12,6 | Skin | |
| Isopentylacetate | 123-92-2 | 204-662-3 | 50 | 270 | 100 | 540 | ||
| Dimethylamine | 124-40-3 | 204-697-4 | 2 | 3,8 | 5 | 9,4 | ||
| N,N-Dimethylacetamide | 127-19-5 | 204-826-4 | 10 | 36 | 20 | 72 | Skin | |
| n-Butylacrylate | 141-32-2 | 205-480-7 | 2 | 11 | 10 | 53 | ||
| n-Heptane | 142-82-5 | 205-563-8 | 500 | 2 085 | ||||
| 1,2,3-Trimethylbenzene | 526-73-8 | 208-394-8 | 20 | 100 | ||||
| 5-Methylheptan-3-one | 541-85-5 | 208-793-7 | 10 | 53 | 20 | 107 | ||
| 1-Methylbutylacetate | 626-38-0 | 210-946-8 | 50 | 270 | 100 | 540 | ||
| Pentylacetate | 628-63-7 | 211-047-3 | 50 | 270 | 100 | 540 | ||
| 3-Pentylacetate | 620-11-1 | 50 | 270 | 100 | 540 | |||
| Amylacetate, tert | 625-16-1 | 50 | 270 | 100 | 540 | |||
| Xylene, mixed isomers, pure | 1330-20-7 | 215-535-7 | 50 | 221 | 100 | 442 | Skin | |
| Sulphotep | 3689-24-5 | 222-995-2 | 0,1 | Skin | ||||
| Hydrogen fluoride | 7664-39-3 | 231-634-8 | 1,8 | 1,5 | 3 | 2,5 | ||
| Silver, metallic | 7440-22-4 | 231-131-3 | 0,1 | |||||
| Hydrogen chloride | 7647-01-0 | 231-595-7 | 5 | 8 | 10 | 15 | ||
| Orthophosphoric acid | 7664-38-2 | 231-633-2 | 1 | 2 | ||||
| Ammonia, anhydrous | 7664-41-7 | 231-635-3 | 20 | 14 | 50 | 36 | ||
| Fluorine | 7782-41-4 | 231-954-8 | 1 | 1,58 | 2 | 3,16 | ||
| Dihydrogen selenide | 7783-07-5 | 231-978-9 | 0,02 | 0,07 | 0,05 | 0,17 | ||
| Hydrogen bromide | 10035-10-6 | 233-113-0 | 2 | 6,7 | ||||
| Sodium azide | 26628-22-8 | 247-852-1 | 0,1 | 0,3 | Skin | |||
| (2-Methoxymethylethoxy)-propanol | 34590-94-8 | 252-104-2 | 50 | 308 | Skin | |||
| Fluorides, inorganic | 2,5 | |||||||
| Nicotine | 54-11-5 | 200-193-3 | 0,5 | skin | ||||
| Formic acid | 64-18-6 | 200-579-1 | 5 | 9 | ||||
| Methanol | 67-56-1 | 200-659-6 | 200 | 260 | skin | |||
| Chloroethane | 75-00-3 | 200-830-5 | 100 | 268 | ||||
| Acetonitrile | 75-05-8 | 200-835-2 | 40 | 70 | skin | |||
| Isopentane | 78-78-4 | 201-142-8 | 1 000 | 3 000 | ||||
| Nitrobenzene | 98-95-3 | 202-716-0 | 0,2 | 1 | skin | |||
| Resorcinol | 108-46-3 | 203-585-2 | 10 | 45 | skin | |||
| Toluene | 108-88-3 | 203-625-9 | 50 | 192 | 100 | 384 | skin | |
| Monochlorobenzene | 108-90-7 | 203-628-5 | 5 | 23 | 15 | 70 | ||
| Pentane | 109-66-0 | 203-692-4 | 1 000 | 3 000 | ||||
| Diethylamine | 109-89-7 | 203-716-3 | 5 | 15 | 10 | 30 | ||
| n-Hexane | 110-54-3 | 203-777-6 | 20 | 72 | ||||
| Cyclohexane | 110-82-7 | 203-806-2 | 200 | 700 | ||||
| Morpholine | 110-91-8 | 203-815-1 | 10 | 36 | 20 | 72 | ||
| 2-(2-Methoxyethoxy)ethanol | 111-77-3 | 203-906-6 | 10 | 50,1 | skin | |||
| 2-(2-Butoxyethoxy)ethanol | 112-34-5 | 203-961-6 | 10 | 67,5 | 15 | 101,2 | ||
| Carbon dioxide | 124-38-9 | 204-696-9 | 5 000 | 9 000 | ||||
| 2-Aminoethanol | 141-43-5 | 205-483-3 | 1 | 2,5 | 3 | 7,6 | skin | |
| Oxalic acid | 144-62-7 | 205-634-3 | 1 | |||||
| Cyanamide | 420-04-2 | 206-992-3 | 0,58 | 1 | skin | |||
| Neopentane | 463-82-1 | 207-343-7 | 1 000 | 3 000 | ||||
| Diphosphorus pentaoxide | 1314-56-3 | 215-236-1 | 1 | |||||
| Diphosphorus pentasulphide | 1314-80-3 | 215-242-4 | 1 | |||||
| Silver (soluble compounds as Ag) | 231-131-3 | 0,01 | ||||||
| Barium (soluble compounds as Ba) | 0,5 | |||||||
| Chromium Metal, Inorganic Chromium (II) Compounds and Inorganic Chromium (III) Compounds (insoluble) | 2 | |||||||
| Nitric acid | 7697-37-2 | 231-714-2 | 1 | 2,6 | ||||
| Bromine | 7726-95-6 | 231-778-1 | 0,1 | 0,7 | ||||
| Chlorine | 7782-50-5 | 231-959-5 | 0,5 | 1,5 | ||||
| Phosphine | 7803-51-2 | 232-260-8 | 0,1 | 0,14 | 0,2 | 0,28 | ||
| Pyrethrum (purified of sensitising lactones) | 8003-34-7 | 1 | ||||||
| Phosphorus pentachloride | 10026-13-8 | 233-060-3 | 1 | |||||
| N,N Dimethylformamide | 68-12-2 | 5 | 15 | 10 | 30 | skin | ||
| Carbon disulphide | 75-15-0 | 5 | 15 | skin | ||||
| Methyl methacrylate | 80-62-6 | 50 | 100 | |||||
| Methylacrylate | 96-33-3 | 5 | 18 | 10 | 36 | |||
| Vinyl acetate | 108-05-4 | 5 | 17,6 | 10 | 35,2 | |||
| Phenol | 108-95-2 | 2 | 8 | 4 | 16 | skin | ||
| 2-Methoxyethanol | 109-86-4 | 1 | skin | |||||
| 2-Methyoxyethyl acetate | 110-49-6 | 1 | skin | |||||
| 2-Ethoxy ethanol | 110-80-5 | 2 | 8 | skin | ||||
| 2-Ethoxyethyl acetate | 111-15-9 | 2 | 11 | skin | ||||
| 1,4 Dioxane | 123-91-1 | 20 | 73 | |||||
| Ethylacrylate | 140-88-5 | 5 | 21 | 10 | 42 | |||
| Methylisocyanate | 624-83-9 | 0,02 | ||||||
| n-Methyl-2-pyrrolidone | 872-50-4 | 10 | 40 | 20 | 80 | skin | ||
| Tertiary-butyl-methyl ether | 1634-04-4 | 50 | 183,5 | 100 | 367 | |||
| Mercury and divalent inorganic mercury compounds including mercuric oxide and mercuric chloride (measured as mercury) | 0,02 | (7) | ||||||
| Sulphuric acid (mist) | 7664-93-9 | 0,05 | thoracic (mist) | (8), (9) | ||||
| Hydrogen sulphide | 7783-06-4 | 5 | 7 | 10 | 14 | |||
| Manganese and inorganic manganese compounds (as manganese) | 0,2 | inhalable | (8) | |||||
| Manganese and inorganic manganese compounds (as manganese) | 0,05 | respirable | (9) | |||||
| Glycerol trinitrate | 55-63-0 | 200-240-8 | 0,01 | 0,095 | 0,02 | 0,19 | skin | |
| Carbon tetrachloride; Tetrachloromethane | 56-23-5 | 200-262-8 | 1 | 6,4 | 5 | 32 | skin | |
| Amitrole | 61-82-5 | 200-521-5 | 0,2 | |||||
| Acetic acid | 64-19-7 | 200-580-7 | 10 | 25 | 20 | 50 | ||
| Hydrogen cyanide (as cyanide) | 74-90-8 | 200-821-6 | 0,9 | 1 | 4,5 | 5 | skin | |
| Methylene chloride; Dichloromethane | 75-09-2 | 200-838-9 | 100 | 353 | 200 | 706 | skin | |
| Vinylidene chloride; 1,1-Dichloroethylene | 75-35-4 | 200-864-0 | 2 | 8 | 5 | 20 | ||
| Tetraethyl orthosilicate | 78-10-4 | 201-083-8 | 5 | 44 | ||||
| Acrylic acid; Prop-2-enoic acid | 79-10-7 | 201-177-9 | 10 | 29 | 20 | 59 | (10) | |
| Nitroethane | 79-24-3 | 201-188-9 | 20 | 62 | 100 | 312 | skin | |
| Bisphenol A; 4,4′-Isopropylidenediphenol | 80-05-7 | 201-245-8 | 2 | inhalable | (8) | |||
| Diphenyl ether | 101-84-8 | 202-981-2 | 1 | 7 | 2 | 14 | ||
| 2-ethylhexan-1-ol | 104-76-7 | 203-234-3 | 1 | 5,4 | ||||
| 1,4-Dichlorobenzene; p-Dichlorobenzene | 106-46-7 | 203-400-5 | 2 | 12 | 10 | 60 | skin | |
| Acrolein; Acrylaldehyde; Prop-2-enal | 107-02-8 | 203-453-4 | 0,02 | 0,05 | 0,05 | 0,12 | ||
| Methyl formate | 107-31-3 | 203-481-7 | 50 | 125 | 100 | 250 | skin | |
| But-2-yne-1,4-diol | 110-65-6 | 203-788-6 | 0,5 | |||||
| Tetrachloroethylene | 127-18-4 | 204-825-9 | 20 | 138 | 40 | 275 | skin | |
| Ethyl acetate | 141-78-6 | 205-500-4 | 200 | 734 | 400 | 1 468 | ||
| Sodium cyanide (as cyanide) | 143-33-9 | 205-599-4 | 1 | 5 | skin | |||
| Potassium cyanide (as cyanide) | 151-50-8 | 205-792-3 | 1 | 5 | skin | |||
| Diacetyl; Butanedione | 431-03-8 | 207-069-8 | 0,02 | 0,07 | 0,1 | 0,36 | ||
| Carbon monoxide | 630-08-0 | 211-128-3 | 20 | 23 | 100 | 117 | ||
| Calcium dihydroxide | 1305-62-0 | 215-137-3 | 1 | 4 | respirable | (9) | ||
| Calcium oxide | 1305-78-8 | 215-138-9 | 1 | 4 | respirable | (9) | ||
| Sulphur dioxide | 7446-09-5 | 231-195-2 | 0,5 | 1,3 | 1 | 2,7 | ||
| Lithium hydride | 7580-67-8 | 231-484-3 | 0,02 | inhalable | (8) | |||
| Nitrogen monoxide | 10102-43-9 | 233-271-0 | 2 | 2,5 | ||||
| Nitrogen dioxide | 10102-44-0 | 233-272-6 | 0,5 | 0,96 | 1 | 1,91 | ||
| Terphenyl, hydrogenated | 61788-32-7 | 262-967-7 | 2 | 19 | 5 | 48 | ||
| Aniline | 62-53-3 | 200-539-3 | 2 | 7,74 | 5 | 19,35 | skin, (8) | |
| Chloromethane | 74-87-3 | 200-817-4 | 20 | 42 | ||||
| Trimethylamine | 75-50-3 | 200-875-0 | 2 | 4,9 | 5 | 12,5 | ||
| 2-Phenylpropane (Cumene) | 98-82-8 | 202-704-5 | 10 | 50 | 50 | 250 | skin, (8) | |
| sec-Butyl acetate | 105-46-4 | 203-300-1 | 50 | 241 | 150 | 723 | ||
| 4-aminotoluene | 106-49-0 | 203-403-1 | 1 | 4,46 | 2 | 8,92 | skin | |
| Isobutyl acetate | 110-19-0 | 203-745-1 | 50 | 241 | 150 | 723 | ||
| Isoamyl alcohol | 123-51-3 | 204-633-5 | 5 | 18 | 10 | 37 | ||
| n-Butyl acetate | 123-86-4 | 204-658-1 | 50 | 241 | 150 | 723 | ||
| Phosphoryl trichloride | 10025-87-3 | 233-046-7 | 0,01 | 0,064 | 0,02 | 0,12 |
Notes legend
As written in the official source.
- (6)
- Existing scientific data on health effects appear to be particularly limited.
- (7)
- During exposure monitoring for mercury and its divalent inorganic compounds, account should be taken of relevant biological monitoring techniques that complement the IOELV.
- (8)
- When selecting an appropriate exposure monitoring method, account should be taken of potential limitations and interferences that may arise in the presence of other sulphur compounds.
- (9)
- The mist is defined as the thoracic fraction.
- (10)
- Short-term exposure limit value in relation to a reference period of 1 minute (applies to the short-term values of 59 mg/m3 and 20 ppm).
- skin
- a skin notation assigned to the occupational exposure limit value indicates the possibility of significant uptake through the skin (footnote 3)
- Skin
- a skin notation assigned to the OEL identifies the possibility of significant uptake through the skin (footnote 3)
Official source
- eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:01991L0322-20180821
- eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02000L0039-20210520
- eur-lex.europa.eu/eli/dir/2006/15/oj
- eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02009L0161-20180821
- eur-lex.europa.eu/eli/dir/2017/164/oj
- eur-lex.europa.eu/eli/dir/2019/1831/oj
Values are copied exactly as published, without conversion or rounding. Not legal advice; always check the official text.